Advanced Enzyme's board of directors on Saturday also approved the collaboration between the company and a developer to set up a group captive wind power plant via a special purpose vehicle (SPV) ...
Explore the role of the cPLA2 enzyme in brain inflammation related to Alzheimer’s disease and its potential as a therapeutic target.
PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may ...
Hunter syndrome (MPS II) presentations will include analysis from continued follow-up of Phase 1/2 data for tividenofusp alfa (DNL310), currently ...
Split-virus influenza vaccines may increase pre-existing neuraminidase inhibition antibody titers in adults up to 6 months ...
I’m not usually the type to wax poetic about skincare, but Leafoberryy’s Mucin Fusion Face Serum feels like someone bottled the concept of “plump, happy skin” a ...
Company expects up to six-month review period per FDA guidelines New longer-term clinical data demonstrating durable positive brain biochemical ...
Undergraduate researchers study a protein that converts omega-6 fatty acids to omega-3 fatty acids, possibly reducing ...
About Chiesi Group Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative ...
Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) ...
By Kamal Choudhury Jan 30 (Reuters) - Shares of Corcept Therapeutics fell 16% on Friday after a corrected "complete response ...
Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results